148 related articles for article (PubMed ID: 29416001)
1. LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway.
Wang J; Xiao Q; Chen X; Tong S; Sun J; Lv R; Wang S; Gou Y; Tan L; Xu J; Fan C; Ding G
Cell Death Dis; 2018 Feb; 9(2):197. PubMed ID: 29416001
[TBL] [Abstract][Full Text] [Related]
2. LanCL1 attenuates ischemia-induced oxidative stress by Sirt3-mediated preservation of mitochondrial function.
Xie Z; Cao BQ; Wang T; Lei Q; Kang T; Ge CY; Gao WJ; Hui H
Brain Res Bull; 2018 Sep; 142():216-223. PubMed ID: 30075199
[TBL] [Abstract][Full Text] [Related]
3. PAGE4 promotes prostate cancer cells survive under oxidative stress through modulating MAPK/JNK/ERK pathway.
Lv C; Fu S; Dong Q; Yu Z; Zhang G; Kong C; Fu C; Zeng Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):24. PubMed ID: 30658679
[TBL] [Abstract][Full Text] [Related]
4. Lanthionine synthetase C-like protein 1 interacts with and inhibits cystathionine β-synthase: a target for neuronal antioxidant defense.
Zhong WX; Wang YB; Peng L; Ge XZ; Zhang J; Liu SS; Zhang XN; Xu ZH; Chen Z; Luo JH
J Biol Chem; 2012 Oct; 287(41):34189-201. PubMed ID: 22891245
[TBL] [Abstract][Full Text] [Related]
5. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
[TBL] [Abstract][Full Text] [Related]
6. Identification of Critical Pathways and Hub Genes in LanCL1-Overexpressed Prostate Cancer Cells.
Tang R; Wu Z; Lu F; Wang C; Wu B; Wang J; Zhu Y
Onco Targets Ther; 2020; 13():7653-7664. PubMed ID: 32821124
[TBL] [Abstract][Full Text] [Related]
7. LANCL1, a cell surface protein, promotes liver tumor initiation through FAM49B-Rac1 axis to suppress oxidative stress.
Huang H; Tsui YM; Ho DW; Chung CY; Sze KM; Lee E; Cheung GC; Zhang VX; Wang X; Lyu X; Ng IO
Hepatology; 2024 Feb; 79(2):323-340. PubMed ID: 37540188
[TBL] [Abstract][Full Text] [Related]
8. The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer.
Hormaechea-Agulla D; Jiménez-Vacas JM; Gómez-Gómez E; L-López F; Carrasco-Valiente J; Valero-Rosa J; Moreno MM; Sánchez-Sánchez R; Ortega-Salas R; Gracia-Navarro F; Culler MD; Ibáñez-Costa A; Gahete MD; Requena MJ; Castaño JP; Luque RM
FASEB J; 2017 Nov; 31(11):4682-4696. PubMed ID: 28705809
[TBL] [Abstract][Full Text] [Related]
9. G protein-coupled receptor GPR160 is associated with apoptosis and cell cycle arrest of prostate cancer cells.
Zhou C; Dai X; Chen Y; Shen Y; Lei S; Xiao T; Bartfai T; Ding J; Wang MW
Oncotarget; 2016 Mar; 7(11):12823-39. PubMed ID: 26871479
[TBL] [Abstract][Full Text] [Related]
10. Developmental and activity-dependent expression of LanCL1 confers antioxidant activity required for neuronal survival.
Huang C; Chen M; Pang D; Bi D; Zou Y; Xia X; Yang W; Luo L; Deng R; Tan H; Zhou L; Yu S; Guo L; Du X; Cui Y; Hu J; Mao Q; Worley PF; Xiao B
Dev Cell; 2014 Aug; 30(4):479-87. PubMed ID: 25158856
[TBL] [Abstract][Full Text] [Related]
11. Stable knockout of lanthionine synthase C-like protein-1 (LanCL1) from HeLa cells indicates a role for LanCL1 in redox regulation of deubiquitinating enzymes.
Downey A; Olcott M; Spector D; Bird K; Ter Doest A; Pierce Z; Quach E; Sparks S; Super C; Naifeh J; Powers A; White M; Hensley K
Free Radic Biol Med; 2020 Dec; 161():115-124. PubMed ID: 33049334
[TBL] [Abstract][Full Text] [Related]
12. Animal models of male subfertility targeted on LanCL1-regulated spermatogenic redox homeostasis.
Huang C; Yang C; Pang D; Li C; Gong H; Cao X; He X; Chen X; Mu B; Cui Y; Liu W; Luo Q; Cheng A; Jia L; Chen M; Xiao B; Chen Z
Lab Anim (NY); 2022 May; 51(5):133-145. PubMed ID: 35469022
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
14. A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.
Fang Z; Xu C; Li Y; Cai X; Ren S; Liu H; Wang Y; Wang F; Chen R; Qu M; Wang Y; Zhu Y; Zhang W; Shi X; Yao J; Gao X; Hou J; Xu C; Sun Y
Cancer Lett; 2016 Apr; 374(1):62-74. PubMed ID: 26808578
[TBL] [Abstract][Full Text] [Related]
15. Relaxin promotes prostate cancer progression.
Feng S; Agoulnik IU; Bogatcheva NV; Kamat AA; Kwabi-Addo B; Li R; Ayala G; Ittmann MM; Agoulnik AI
Clin Cancer Res; 2007 Mar; 13(6):1695-702. PubMed ID: 17363522
[TBL] [Abstract][Full Text] [Related]
16. MiR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression.
Li F; Gu C; Tian F; Jia Z; Meng Z; Ding Y; Yang J
Oncol Rep; 2016 May; 35(5):2859-65. PubMed ID: 26986507
[TBL] [Abstract][Full Text] [Related]
17. LanCL proteins are not Involved in Lanthionine Synthesis in Mammals.
He C; Zeng M; Dutta D; Koh TH; Chen J; van der Donk WA
Sci Rep; 2017 Jan; 7():40980. PubMed ID: 28106097
[TBL] [Abstract][Full Text] [Related]
18. Oleic acid promotes prostate cancer malignant phenotype via the G protein-coupled receptor FFA1/GPR40.
Liotti A; Cosimato V; Mirra P; Calì G; Conza D; Secondo A; Luongo G; Terracciano D; Formisano P; Beguinot F; Insabato L; Ulianich L
J Cell Physiol; 2018 Sep; 233(9):7367-7378. PubMed ID: 29663374
[TBL] [Abstract][Full Text] [Related]
19. The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness.
Hormaechea-Agulla D; Gahete MD; Jiménez-Vacas JM; Gómez-Gómez E; Ibáñez-Costa A; L-López F; Rivero-Cortés E; Sarmento-Cabral A; Valero-Rosa J; Carrasco-Valiente J; Sánchez-Sánchez R; Ortega-Salas R; Moreno MM; Tsomaia N; Swanson SM; Culler MD; Requena MJ; Castaño JP; Luque RM
Mol Cancer; 2017 Aug; 16(1):146. PubMed ID: 28851363
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells.
Zhu B; Li X; Zhang Y; Ye C; Wang Y; Cai S; Huang H; Cai Y; Yeh S; Huang Z; Chen R; Tao Y; Wen X
Int J Cancer; 2013 May; 132(10):2270-82. PubMed ID: 23129185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
